Stock Market & Financial News
Market Midday: Stocks Lower; U.S. Hormuz Blockade Sends Oil Higher • 7/13/26
The CNBC Business News Update with Jessica Ettinger features market numbers & news with CNBC expert analysis and sound from top business names. Updated throughout the business day.
BNO U.S. Dollar Moves Higher As Oil Gains 5%: Analysis For EUR/USD, GBP/USD, USD/CAD, USD/JPY
Rising geopolitical tensions provided support to the American currency.
Autonomix Medical wins new patent for neural sensing technology
Autonomix Medical Inc (NASDAQ:AMIX) has been granted a new patent strengthening its neural sensing intellectual property, the company said, adding to a portfolio it ties to what it called the multi-billion-dollar denervation market. Autonomix said the patent grant covers its neural sensing technology and reinforces its intellectual property position.
AMIX Meta's $125 Billion AI Push Is Turning Heads on Wall Street
$125 billion to $145 billion. That is what Meta Platforms (NASDAQ:META | META Price Prediction) now expects to spend on capital expenditures in 2026, raised from a prior range of $120 to $135 billion when the company reported first-quarter results on April 29, 2026.
META 
Jim Cramer Says META's AI Model Change Was Worth 100 Points: Here's Why He Can't Stop Buying Big Tech
Jim Cramer says a single AI product decision at Meta Platforms (NASDAQ:META | META Price Prediction) just moved the stock roughly $100 per share, and he is using it as Exhibit A for why big tech is nearly impossible to trim.
META 
Micron Technology Will Continue The Ride, Here's Why
Micron Technology, Inc. was my best investment of 2025 and generated nearly 1,400% return since April 2025 when I rated it a Strong Buy. MU has been one of my key holdings ever since. And I've been adding regularly. Now, the stock price has just dropped ~20% from its ATH. And it left investors wondering whether it's a time to sell or buy even more.
MU 
The Phase 3 Failure That Sent Biotech Winners and Losers in Opposite Directions
When a late-stage clinical trial misses a primary endpoint, the market reaction rarely distributes evenly across the board. The fallout often reveals undeniable fundamental truths about single-asset exposure, pipeline diversification, and the competitive moats protecting established treatments.
WNRS 
Ledger Unlocks Seamless Celo Fee Abstraction With Powerful CIP‑64 Integration
Ledger expanded its support for Celo, the Ethereum layer-2 network oriented toward global finance. The fee abstraction functionality was enabled through the integration of CIP-64. With this update, Ledger's more than 8 million users can use any of the 18 native Celo assets available on the platform to pay transaction fees, with no need to hold the CELO token as gas.
Greenfire Resources plans C$575M rights offering to fund Connacher deal
Greenfire Resources Ltd. (NYSE:GFR, TSX:GFR) plans to raise at least C$575 million through a rights offering to help fund its proposed acquisition of Connacher Oil and Gas Limited, with majority shareholder Waterous Energy Fund backstopping the entire amount.
GFR 
JNJ Vs. KO: Which Dividend Stock Is The Better Buy?
Johnson & Johnson (NYSE:JNJ | JNJ Price Prediction) and Coca-Cola (NYSE:KO) both delivered Q1 2026 beats and both are being crowded into by capital rotating out of tech.
JNJ 
Is UiPath's 6-Month Pullback Creating an Investment Opportunity?
PATH's six-month pullback comes as AI adoption, enterprise customer growth and profitability improve, creating a more attractive entry point.
PATH 
AVNT's Dyneema DM20 Fiber Earns ClassNK Approval for FOWT Applications
Avient's Dyneema DM20 fiber gains ClassNK approval for floating offshore wind mooring systems, supporting wider adoption in Japan's expanding market.
AVNT 
Kraken becomes first major US exchange to support USDC.e on Tempo network
Kraken's support for USDC.e on Tempo could accelerate stablecoin adoption in fintech, but liquidity and geographic limits may hinder growth. Kraken becomes first major US exchange to support USDC.e on Tempo network.
Strategy adds $467M in cash, no Bitcoin, as analysts warn Saylor needs clearer pivot message
Strategy's unclear pivot and cash reserve focus may destabilize Bitcoin market sentiment, highlighting the need for transparent communication. Strategy adds $467M in cash, no Bitcoin, as analysts warn Saylor needs clearer pivot message.
SSR Mining: A Proven Playbook And A Fresh War Chest
SSR Mining (SSRM) is now a pure-play Americas gold and silver producer with $2.1B net cash after divesting Çöpler. SSRM's four operating mines generate robust free cash flow, supporting a 10% FCF yield and ongoing capital deployment opportunities. The stock trades at 0.7x NAV with a Buy rating and $40 price target, reflecting confidence in management's acquisition strategy.
SSRM 
Missed GE's Aerospace Rally? XLI Holders Made More Money
GE Aerospace (NYSE:GE | GE Price Prediction) is having a moment.
XLI 
IonQ Tumbles 8%, D-Wave, Rigetti, Quantum Computing Drop 6% as Risk-Off Ripple Effects Hit Speculative Quantum Stocks
Quantum computing stocks are the sharpest casualties in Monday morning trading, with the group selling off in unison even though there is no company-specific news driving the move.
IONQ 
Meta yanks controversial AI image tool after privacy backlash: ‘Force their slop down everyone's throat'
The Instagram, Facebook and WhatsApp owner last Tuesday launched Muse Image, its first AI image generator meant to compete with OpenAI's ChatGPT Images 2.0 and Google's Nano Banana 2.
META 
Changpeng Zhao Burns BNB Chain Memecoins and Denies Links to $CZ, $TCC and $AB
Changpeng Zhao burned spam memecoins sent to his BNB Chain wallet and denied any connection to $CZ, $TCC, and $AB.
FDA Expands MRK & PFE's Keytruda-Padcev Combo Use in Bladder Cancer
Merck's Keytruda in combination with Pfizer's Padcev wins FDA nod for expanded use in muscle-invasive bladder cancer, regardless of cisplatin eligibility.
MRK 
Jim Cramer Says Buy IBM Right Now: Here Is Why Arvind Krishna Has This Stock Undervalued
At $292.59, International Business Machines (NYSE:IBM | IBM Price Prediction) is a Buy, echoing Jim Cramer's call on Mad Money after a viewer asked for a verdict on the stock.
IBM 
FuboTV shares pop on appointment of former Disney+ executive Alisa Bowen as CEO
FuboTV (NYSE: FUBO) shares climbed about 11% after the company appointed former Disney+ president Alisa Bowen as its new chief executive officer, replacing co-founder David Gandler. The company announced that Bowen assumed the role on July 10, bringing nearly three decades of experience across media, digital products and operations.
FUBO 
Elon Musk, Sam Altman feud reignites after Apple sues OpenAI for stealing trade secrets: ‘Scam Altman'
In a Saturday post on X, Musk invoked his longtime nickname for Altman, writing: “Scam Altman strikes again
AAPL 
Planet Labs dives as space stocks reverse after the SpaceX IPO: buy the dip?
Planet Labs stock continued its strong downward trend last week, reaching its lowest level since March 19. PL has dropped by 50% from its highest point this year, with the market capitalization falling from over $18.40 billion in May to the current $9.28 billion, and technicals suggest that it has more downside to go.
PL 
Don't Miss These 2 Energy Stocks Before Q2 Earnings Season Kicks Off
Par Pacific and Patterson-UTI enter Q2 earnings season with support from favorable refining and drilling trends.
PARR 
GigaCloud: Flawless Execution At A Bargain Basement Price
GigaCloud (GCT) is deeply undervalued despite double-digit revenue and earnings growth, a pristine balance sheet, and a unique, scalable B2B logistics platform. GCT's operational efficiency, expanding international presence, and robust free cash flow yield above 10% underpin its competitive advantage and margin stability. Management prioritizes profitable growth, maintains gross margins near 24%, and actively returns capital via buybacks, with over $77M remaining under the current program.
GCT 
Vita Coco: Strong Potential Overseas Yet Valuation Remains Stretched
The Vita Coco Company (COCO) continues to deliver strong sales growth, with international expansion—especially in Europe—highlighted as a major catalyst. Q1 2026 revenue grew 37% YoY to $180M, with gross margins improving to 40% and management raising full-year guidance for both sales and EBITDA. COCO maintains a robust balance sheet with no long-term debt and $200M in cash, but remains highly dependent on its core coconut water brand and a concentrated customer base.
COCO 
Top 10 Charts of 2026: Mid-Year Review
Navigating the macroeconomic landscape in the first half of 2026 has been a study in contrasts. Markets have marched toward all-time highs even as historic valuation metrics flash warning signs behind the scenes.
CAPE 
Q32 Bio's Bempikibart Shows Durable Hair Regrowth in Phase 2 Alopecia Study
Q32 Bio NASDAQ: QTTB reported positive 36-week top-line results from Part B of its SIGNAL-AA Phase 2a clinical trial evaluating bempikibart in patients with severe and very severe alopecia areata, a disease that causes hair loss and can carry a significant psychosocial burden.
QTTB 
Strategy Taps ATM Program for Fresh Funds and Leaves Its Bitcoin Position Unmoved
Strategy raised $466.7 million through the sale of 4.8 million Class A shares via its at-the-market offering program (ATM), according to a Form 8-K filed with the U.S. Securities and Exchange Commission (SEC). The transaction was executed between July 6 and 12.
